Jonne Housh
Family · Phoenix, AZNPI 1285847210
Payments from drug & device makers
Across 202 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Scynexis, Inc.$916
- Pfizer$453
- Lilly USA, LLC$294
- Novo Nordisk$289
- Abbott$152
- plus $805 from 17 others
What the payments were for
- Consulting fees$75019%
- Food & beverage$3,17581%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,027 |
| Scynexis, Inc. | 4 | $916 |
| Pfizer | 25 | $453 |
| Lilly USA, LLC | 22 | $294 |
| Novo Nordisk | 21 | $289 |
| Abbott | 8 | $152 |
| AstraZeneca | 8 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $97 |
| Shield Therapeutics Inc | 4 | $94 |
| Kaleo, Inc. | 3 | $83 |
| Bausch Health US, LLC | 4 | $76 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Amgen | 3 | $46 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| IBSA Pharma Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Novartis | 1 | $13 |
How this compares
$3,936 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $41,484 |
| TrulicityDulaglutide | 12 | $28,207 |
| Liothyronine Sodium | 33 | $1,790 |
| ProgesteroneProgesterone, Micronized | 37 | $1,612 |
| Risedronate Sodium | 16 | $1,515 |
| SynthroidLevothyroxine Sodium | 15 | $1,260 |
| Np ThyroidThyroid,pork | 16 | $1,025 |
| Fenofibric AcidFenofibric Acid (Choline) | 20 | $943 |
| Bupropion XlBupropion Hcl | 20 | $791 |
| Levothyroxine Sodium | 85 | $649 |
| Ezetimibe | 20 | $555 |
| Rosuvastatin Calcium | 69 | $504 |
| Pravastatin Sodium | 27 | $306 |
| Lisinopril | 66 | $273 |
| Metformin Hcl ErMetformin Hcl | 15 | $232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $289 | $41,48418 claims |
| Lilly USA, LLCTrulicity | $294 | $28,20712 claims |
| AbbVieSynthroid | $1,027 | $1,26015 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $15 | $1,02516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.
Other family in Phoenix
- Kimberly HallaPhoenix$332K
- Audrey StevensonPhoenix$83K
- Rebekah EdwardsPhoenix$51K
- Tirsa QuartulloPhoenix$31K
- Jessica AcostaPhoenix$30K
- Stephanie JohnstonPhoenix$25K
- Kelly MarcelloPhoenix$23K
- Judith BergmanPhoenix$22K
- Lauren BonnerPhoenix$22K
- Rita GonzalezPhoenix$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.